erk 745 inhibitor u0126 (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
98
Structured Review
MedChemExpress
erk 745 inhibitor u0126
Erk 745 Inhibitor U0126, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 455 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk+745+inhibitor+u0126/U0126/10__1016_slash_j__isci__2026__115779-734-94-100
Average 98 stars, based on 455 article reviews
Erk 745 Inhibitor U0126, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 98/100, based on 455 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erk+745+inhibitor+u0126/U0126/10__1016_slash_j__isci__2026__115779-734-94-100
Average 98 stars, based on 455 article reviews
erk 745 inhibitor u0126 - by Bioz Stars,
2026-11
98/100 stars
Images
Related Articles
Cell Culture:Article Title: Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway Article Snippet: In short, cells were cultured with RPMI 1640 (Thermo, Cat# 11879020) 738 without glucose and FBS in a 95% N2 and 5% CO2 chamber for two hours. .. After hypoxia, the RPMI 1640 739 was replaced with DMEM and cultured in a 95% air and 5% CO2 incubator for 24 h. While performing 740 reoxygenation, the following medications were added: non-selective β-AR blocker propranolol (10 μM, 741 Sigma-Aldrich, Cat# 40543), non-selective β-AR agonist isoproterenol (10 μM, Sigma-Aldrich, Cat# 742 16504), β1-AR agonist dobutamine (0.5 μM, MCE, Cat# HY-15746A), β1-AR blocker betaxolol (0.3 μM, 743 MCE, Cat# HY-B0381), β2-AR agonist salmeterol (0.5 μM, MCE, Cat# HY-14302), β2-AR blocker 744 ICI118,551 (0.3 μM, MCE, Cat# HY-13951), PKA inhibitor H-89 (10 μM, MCE, Cat# HY-15979A), Medications:Article Title: Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway Article Snippet: In short, cells were cultured with RPMI 1640 (Thermo, Cat# 11879020) 738 without glucose and FBS in a 95% N2 and 5% CO2 chamber for two hours. .. After hypoxia, the RPMI 1640 739 was replaced with DMEM and cultured in a 95% air and 5% CO2 incubator for 24 h. While performing 740 reoxygenation, the following medications were added: non-selective β-AR blocker propranolol (10 μM, 741 Sigma-Aldrich, Cat# 40543), non-selective β-AR agonist isoproterenol (10 μM, Sigma-Aldrich, Cat# 742 16504), β1-AR agonist dobutamine (0.5 μM, MCE, Cat# HY-15746A), β1-AR blocker betaxolol (0.3 μM, 743 MCE, Cat# HY-B0381), β2-AR agonist salmeterol (0.5 μM, MCE, Cat# HY-14302), β2-AR blocker 744 ICI118,551 (0.3 μM, MCE, Cat# HY-13951), PKA inhibitor H-89 (10 μM, MCE, Cat# HY-15979A), |